investorscraft@gmail.com

Intrinsic Value of BioMarin Pharmaceutical Inc. (BMRN)

Previous Close$83.51
Intrinsic Value
Upside potential
Previous Close
$83.51

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2022-12-31 and quarterly data as of 2023-09-30.

  1. Annual
  2. Quarterly YoY
  3. Quarterly QoQ

Annual revenue growth rates, % (past and forecasted)

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year(a)2023202420252026202720282029203020312032203320342035203620372038203920402041204220432044204520462047

INCOME STATEMENT

Revenue growth rate, %13.5NaN
Revenue, $2096NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $m1946NaN
Operating income, $m150NaN
EBITDA, $m255NaN
Interest expense (income), $mNaN
Earnings before tax, $m150NaN
Tax expense, $m8NaN
Net income, $m142NaN

BALANCE SHEET

Cash and short-term investments, $m1292NaN
Total assets, $m6375NaN
Adjusted assets (=assets-cash), $m5084NaN
Average production assets, $m1614NaN
Working capital, $m2163NaN
Total debt, $m1093NaN
Total liabilities, $m1772NaN
Total equity, $m4603NaN
Debt-to-equity ratio0.237NaN
Adjusted equity ratio0.653NaN

CASH FLOW

Net income, $m142NaN
Depreciation, amort., depletion, $m105NaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $m176NaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $m-121NaN
Free cash flow, $m297NaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $m2163
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount